CVS Health Corp (NYSE:CVS) Stock Position Raised by CLARET ASSET MANAGEMENT Corp

CLARET ASSET MANAGEMENT Corp lifted its holdings in shares of CVS Health Corp (NYSE:CVS) by 3.5% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 128,319 shares of the pharmacy operator’s stock after buying an additional 4,397 shares during the period. CVS Health accounts for approximately 1.7% of CLARET ASSET MANAGEMENT Corp’s holdings, making the stock its 17th biggest position. CLARET ASSET MANAGEMENT Corp’s holdings in CVS Health were worth $8,093,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in CVS. Baldwin Brothers Inc. MA lifted its stake in CVS Health by 1.1% during the third quarter. Baldwin Brothers Inc. MA now owns 14,911 shares of the pharmacy operator’s stock valued at $941,000 after purchasing an additional 165 shares during the last quarter. Mutual Advisors LLC lifted its stake in CVS Health by 0.8% during the second quarter. Mutual Advisors LLC now owns 20,641 shares of the pharmacy operator’s stock valued at $1,125,000 after purchasing an additional 172 shares during the last quarter. Fiduciary Group LLC lifted its stake in CVS Health by 3.2% during the second quarter. Fiduciary Group LLC now owns 6,485 shares of the pharmacy operator’s stock valued at $353,000 after purchasing an additional 200 shares during the last quarter. Legacy Advisors LLC lifted its stake in CVS Health by 2.5% during the third quarter. Legacy Advisors LLC now owns 8,048 shares of the pharmacy operator’s stock valued at $508,000 after purchasing an additional 200 shares during the last quarter. Finally, Carlton Hofferkamp & Jenks Wealth Management LLC lifted its stake in CVS Health by 1.5% during the third quarter. Carlton Hofferkamp & Jenks Wealth Management LLC now owns 13,255 shares of the pharmacy operator’s stock valued at $824,000 after purchasing an additional 201 shares during the last quarter. 75.91% of the stock is owned by institutional investors and hedge funds.

In other news, EVP Joshua Matthew Flum sold 17,703 shares of the stock in a transaction on Monday, September 30th. The shares were sold at an average price of $63.00, for a total transaction of $1,115,289.00. Following the transaction, the executive vice president now owns 36,163 shares in the company, valued at approximately $2,278,269. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Eva C. Boratto sold 8,130 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $65.00, for a total transaction of $528,450.00. Following the transaction, the chief financial officer now owns 55,273 shares in the company, valued at approximately $3,592,745. The disclosure for this sale can be found here. 0.53% of the stock is owned by corporate insiders.



CVS has been the subject of several recent research reports. ValuEngine raised shares of CVS Health from a “strong sell” rating to a “sell” rating in a research note on Wednesday, October 2nd. Bank of America increased their target price on shares of CVS Health from $72.00 to $75.00 and gave the company a “buy” rating in a research note on Thursday, September 12th. Cowen reissued an “outperform” rating and set a $76.00 target price (up from $69.00) on shares of CVS Health in a research note on Tuesday, August 27th. TheStreet raised shares of CVS Health from a “c+” rating to a “b-” rating in a research note on Monday, September 9th. Finally, Royal Bank of Canada began coverage on shares of CVS Health in a research report on Friday, September 27th. They issued an “outperform” rating and a $85.00 price target for the company. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $75.39.

CVS stock traded up $1.22 during midday trading on Friday, reaching $63.36. The company had a trading volume of 3,486,999 shares, compared to its average volume of 6,237,457. CVS Health Corp has a 1 year low of $51.72 and a 1 year high of $82.15. The company has a current ratio of 0.95, a quick ratio of 0.64 and a debt-to-equity ratio of 1.39. The company has a market capitalization of $78.52 billion, a P/E ratio of 8.95, a PEG ratio of 1.32 and a beta of 0.86. The company has a 50 day moving average of $62.12 and a two-hundred day moving average of $56.71.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.70 by $0.19. CVS Health had a net margin of 1.91% and a return on equity of 16.15%. The company had revenue of $63.43 billion during the quarter, compared to the consensus estimate of $62.66 billion. During the same quarter in the prior year, the firm earned $1.69 EPS. The company’s revenue was up 35.2% compared to the same quarter last year. On average, sell-side analysts anticipate that CVS Health Corp will post 6.97 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, November 4th. Shareholders of record on Thursday, October 24th will be given a $0.50 dividend. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $2.00 dividend on an annualized basis and a yield of 3.16%. CVS Health’s payout ratio is 28.25%.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Featured Article: What is a dead cat bounce?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.